PL360122A1 - Kompozycje farmaceutyczne zawierające alginiany - Google Patents

Kompozycje farmaceutyczne zawierające alginiany

Info

Publication number
PL360122A1
PL360122A1 PL01360122A PL36012201A PL360122A1 PL 360122 A1 PL360122 A1 PL 360122A1 PL 01360122 A PL01360122 A PL 01360122A PL 36012201 A PL36012201 A PL 36012201A PL 360122 A1 PL360122 A1 PL 360122A1
Authority
PL
Poland
Prior art keywords
alginic acid
pharmaceutical compositions
compositions including
including alginates
cells
Prior art date
Application number
PL01360122A
Other languages
English (en)
Other versions
PL200402B1 (pl
Inventor
Peter William Dettmar
Ian Gordon Jolliffe
Frank Chadwick Hampson
Peter Edward Ross
Edvar Onsoyen
Paul Murray Mcpherson
Massimo Pignatelli
Buono Raffaele Del
Original Assignee
Reckitt Benckiser Healthcare (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare (Uk) Limited filed Critical Reckitt Benckiser Healthcare (Uk) Limited
Publication of PL360122A1 publication Critical patent/PL360122A1/pl
Publication of PL200402B1 publication Critical patent/PL200402B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL360122A 2000-03-10 2001-03-09 Kompozycje farmaceutyczne zawierające alginiany do stosowania w leczeniu komórek błon śluzowych, ich zastosowanie oraz sposób ich wytwarzania PL200402B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0005743.0A GB0005743D0 (en) 2000-03-10 2000-03-10 Pharmaceutical compositions including alginates

Publications (2)

Publication Number Publication Date
PL360122A1 true PL360122A1 (pl) 2004-09-06
PL200402B1 PL200402B1 (pl) 2009-01-30

Family

ID=9887321

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360122A PL200402B1 (pl) 2000-03-10 2001-03-09 Kompozycje farmaceutyczne zawierające alginiany do stosowania w leczeniu komórek błon śluzowych, ich zastosowanie oraz sposób ich wytwarzania

Country Status (14)

Country Link
US (1) US7776839B2 (pl)
EP (1) EP1265623B1 (pl)
CN (1) CN1265798C (pl)
AT (1) ATE268181T1 (pl)
AU (2) AU2001244298B2 (pl)
BR (1) BR0109139B1 (pl)
CA (1) CA2402449C (pl)
DE (1) DE60103619T2 (pl)
ES (1) ES2217126T3 (pl)
GB (2) GB0005743D0 (pl)
MX (1) MXPA02008842A (pl)
PL (1) PL200402B1 (pl)
WO (1) WO2001066119A2 (pl)
ZA (1) ZA200207994B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
SE530184C2 (sv) 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
EP1859786A1 (en) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
ES2664895T3 (es) 2006-11-07 2018-04-23 The Procter & Gamble Company Composiciones que contienen fibra y métodos de fabricación y uso de las mismas
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
RU2527894C2 (ru) * 2007-11-27 2014-09-10 Альгифарма ИПР АС Использование альгинатных олигомеров в борьбе с биопленками
RU2582938C2 (ru) 2009-06-03 2016-04-27 АльгиФарма АС Альгинатные олигомеры для применения в преодолении множественной лекарственной устойчивости у бактерий
DE102016113017A1 (de) 2016-07-14 2018-01-18 Abbas Mirshafiey Pharmazeutische Verwendung von alpha-L-Guluronsäure
DE102016113018A1 (de) 2016-07-14 2018-01-18 Abbas Mirshafiey Pharmazeutische Verwendung von beta-D-Mannuronsäure

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
DE3152319C2 (de) * 1980-09-03 1986-05-07 Kyosei Pharmaceutical Co., Ltd., Hokkaido Verwendung einer Lösung eines Salzes der Alginsäure zur Behandlung von Strahlenschäden und Ulcera
JPS5746920A (en) * 1980-09-03 1982-03-17 Kyosei Seiyaku Kk Drug for digestive tract
JPH0482832A (ja) * 1988-09-20 1992-03-16 Glaxo Group Ltd 医薬組成物
WO1991011205A1 (en) * 1990-01-23 1991-08-08 Trancel Corporation Mannuronic acid containing alginate wound healing composition and method
JP2643669B2 (ja) * 1990-12-28 1997-08-20 共成製薬株式会社 アルギン含有食品
DE4204012A1 (de) * 1992-02-12 1993-08-19 Ulrich Prof Dr Zimmermann Mitogenfreie substanz, deren herstellung und verwendung
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
ATE291617T1 (de) * 1997-01-24 2005-04-15 Avi Biopharm Inc Verfahren und konjugat zur behandlung von helicobacter pylori-infektionen
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
PL194696B1 (pl) * 1997-04-30 2007-06-29 Reckitt Benckiser Healthcare Kompozycja w stałej postaci dawkowania zawierająca alginiany
EP1023087A2 (en) * 1997-10-17 2000-08-02 Advanced Medical Solutions Limited Foam materials

Also Published As

Publication number Publication date
US7776839B2 (en) 2010-08-17
DE60103619D1 (de) 2004-07-08
GB0005743D0 (en) 2000-05-03
PL200402B1 (pl) 2009-01-30
CA2402449A1 (en) 2001-09-13
BR0109139B1 (pt) 2013-09-03
GB2362103A (en) 2001-11-14
ATE268181T1 (de) 2004-06-15
GB0105837D0 (en) 2001-04-25
ES2217126T3 (es) 2004-11-01
WO2001066119A3 (en) 2002-03-14
ZA200207994B (en) 2003-10-06
GB2362103B (en) 2002-10-16
AU2001244298B2 (en) 2004-10-21
BR0109139A (pt) 2002-12-03
WO2001066119A2 (en) 2001-09-13
CN1265798C (zh) 2006-07-26
EP1265623B1 (en) 2004-06-02
CA2402449C (en) 2011-02-15
CN1420780A (zh) 2003-05-28
US20030130229A1 (en) 2003-07-10
EP1265623A2 (en) 2002-12-18
MXPA02008842A (es) 2003-04-25
AU4429801A (en) 2001-09-17
DE60103619T2 (de) 2005-06-16

Similar Documents

Publication Publication Date Title
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
ATE469633T1 (de) Zahnpflegezusammensetzungen
IL144361A0 (en) Gcsf conjugates
DE69412250D1 (de) Pyridobismidazole enthaltendes rigid-rod-Polymer
BR9910297A (pt) Novos análogos graxos para o tratamento de diabetes
MY114945A (en) Oral composition
HRP20031003A2 (en) 4'-substituted nukleosides
CA2407100A1 (en) 1-aroyl-piperidinyl benzamidines
PL358281A1 (pl) Nowe związki
NZ520624A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
EP1153924A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
IL150223A (en) Lipopeptides and pharmaceuticals containing them
HK1052346A1 (zh) 有效用作β-2-肾上腺素受体激动剂以及PDE4-抑制剂的化合物
CA2279200A1 (en) Anaesthetic bone cement
GB2362103B (en) Pharmaceutical compositions including alginates
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
CA2278133A1 (en) Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
SI1638582T1 (sl) Uporaba hialuronske kisline za pripravo sestav za zdravljenje ponavljajoäśih se aft v ustni votlini
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
RU2001135821A (ru) Состав для полости рта, содержащий перлит
WO2002011740A3 (en) 'slow release' pharmaceutical compositions comprising lithium carbonate
GR3033649T3 (en) Growth factor compositions, preparation and use.
MXPA02006250A (es) Derivados de butino diol.

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140309